Study of Taxoprexin Injection vs. Dacarbazine in Patients With Metastatic Malignant Melanoma

Clinical trial NCT00087776 · TERMINATED

Trial details

NCT number: NCT00087776
Sponsor: American Regent, Inc.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Malignant Melanoma

Start date: 2002-12-06
Primary completion: 2007-10-27
Enrollment: 393

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.